Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ranbaxy moves court to halt Elder's 'ride' on pain-reliever brand Volini

This article was originally published in Scrip

Executive Summary

Ranbaxy Laboratories has initiated legal action against Elder Pharmaceuticals charging the latter with deliberately trying to "ride" on its reputation in a case concerning Ranbaxy's top-selling OTC topical pain-reliever brand, Volini.

You may also be interested in...



Sun Wards Off Volini Infringers, Makes It Count Too

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.

Sun Wards Off Volini Infringers, Makes It Count Too

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.

COVID-19, Lockdown Affect Trials in India But Coping Efforts In Hand

The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.

Topics

Related Companies

UsernamePublicRestriction

Register

SC023470

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel